Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer.
Basser RL, Rasko JE, Clarke K, Cebon J, Green MD, Grigg AP, Zalcberg J, Cohen B, O'Byrne J, Menchaca DM, Fox RM, Begley CG. Basser RL, et al. Among authors: zalcberg j. Blood. 1997 May 1;89(9):3118-28. Blood. 1997. PMID: 9129014 Free article. Clinical Trial.
Recent advances in the treatment of colorectal cancer.
Wirth A, Green M, Penfold C, Hurley R, Matthews J, Burns I, Zalcberg J. Wirth A, et al. Among authors: zalcberg j. Aust N Z J Med. 1992 Feb;22(1):61-8. doi: 10.1111/j.1445-5994.1992.tb01713.x. Aust N Z J Med. 1992. PMID: 1580867 Review. No abstract available.
Adjuvant therapy of colorectal cancer: an overview.
Wirth A, Green M, Zalcberg JR. Wirth A, et al. Among authors: zalcberg jr. Aust N Z J Surg. 1991 Jan;61(1):13-22. doi: 10.1111/j.1445-2197.1991.tb00119.x. Aust N Z J Surg. 1991. PMID: 1994878 Review.
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study.
Prince HM, Millward MJ, Rischin D, Blakey D, Francis P, Gates P, Chapple P, Quinn M, Juneja S, Wolf M, Januszewicz EH, Seymour JF, Brettell M, Strickland A, Zalcberg J, Richardson G, Scarlett J, Briggs P, Toner GC. Prince HM, et al. Among authors: zalcberg j. Ann Oncol. 1999 Apr;10(4):479-81. doi: 10.1023/a:1008317205955. Ann Oncol. 1999. PMID: 10370794 Free article. Clinical Trial.
Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors.
Talbot SM, Westerman DA, Grigg AP, Toner GC, Wolf M, Bishop J, McKendrick J, Zalcberg J, Levi J, Fox RM, Green MD. Talbot SM, et al. Among authors: zalcberg j. Ann Oncol. 1999 Aug;10(8):907-14. doi: 10.1023/a:1008353522601. Ann Oncol. 1999. PMID: 10509151 Free article. Clinical Trial.
410 results